Proteome's full year 2006 loss up 14.6%

UK-based applied proteomics specialist Proteome Sciences says that, for the year ended December 31, 2006, its loss was L4.7 million ($9.5 million) which, excluding non-cash costs and losses incurred by associate companies, represents a 14.6% increase on the deficit it recorded in the year-earlier period. Loss per share increased L0.32, or 10%, to L3.54.

The firm added that non-cash costs (amortization of goodwill, amounts written off fixed asset investments, depreciation and national insurance on notional share option gains) for the period were L855,987, down from L1.2 million in 2005.

Biomarker operations and TMT patents